These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1778293)

  • 21. [Use of sulprostone in the evacuation of molar pregnancies].
    Pinet C; Colau JC
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trichosanthin in the treatment of hydatidiform mole. Clinical analysis of 52 cases.
    Lu PX; Jin YC
    Chin Med J (Engl); 1990 Mar; 103(3):183-5. PubMed ID: 2164464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydatidiform mole in Victoria: aetiology and natural history.
    Olesnicky G; Long AR; Quinn MA; Pepperell RJ; Fortune DW; Kneale BL
    Aust N Z J Obstet Gynaecol; 1985 Feb; 25(1):1-7. PubMed ID: 3862400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibin: a new circulating marker of hydatidiform mole?
    Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
    BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of the primary hydatidiform mole.
    Berkowitz RS; Goldstein DP
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):491-503. PubMed ID: 3067171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased gestational age at evacuation of a complete hydatidiform mole: does it correlate with increased risk of requiring chemotherapy?
    Seckl MJ; Dhillon T; Dancey G; Foskett M; Paradinas FJ; Rees HC; Sebire N; Vigushin DM; Newlands ES
    J Reprod Med; 2004 Jul; 49(7):527-30. PubMed ID: 15305823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase activity in complete hydatidiform mole.
    Bae SN; Kim SJ
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of different technics of uterine evacuation as a risk factor for invasive and metastatic trophoblastic neoplasms].
    de Andrade JM; Bighetti S; Kim TY; de Freitas MM
    AMB Rev Assoc Med Bras; 1989; 35(5):175-8. PubMed ID: 2486413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repetitive complete and partial hydatidiform mole.
    Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of hysteroscopy in diagnosis and management of trophoblastic disease].
    Suzuki A; Kawaguchi K; Konishi I; Ida K; Fujii S; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Feb; 36(2):255-60. PubMed ID: 6321615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent gestational trophoblastic disease following evacuation of a tetraploid partial hydatidiform mole.
    Appelman Z; Dgani R; Zalel Y; Elchalal U; Caspi B
    Gynecol Oncol; 1992 Jan; 44(1):101-3. PubMed ID: 1730416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic hysterectomy for persistent gestational trophoblastic neoplasia.
    Lang JF; Childers JM; Surwit EA
    J Am Assoc Gynecol Laparosc; 1995 Aug; 2(4):475-7. PubMed ID: 9050606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Aziz MF; Kampono N; Moegni EM; Sjamsuddin S; Barnas B; Samil RS
    Adv Exp Med Biol; 1984; 176():165-75. PubMed ID: 6093460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of persistent disease in women with complete hydatidiform mole.
    Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
    J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of endometrial curettage in the follow-up of hydatidiform mole.
    Flam F; Lundström V
    Acta Obstet Gynecol Scand; 1988; 67(7):649-51. PubMed ID: 3247837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of uterine re-curettage, pre-evacuation and week-one level of hCG on the number of chemotherapy courses in treatment of post molar GTN.
    Hemida RA; Toson E; Van Doorn HC
    J Exp Ther Oncol; 2011; 9(3):217-20. PubMed ID: 22070053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy.
    Uberti EM; Fajardo Mdo C; Ferreira SV; Pereira MV; Seger RC; Moreira MA; Torres MD; de Nápoli G; Schmid H
    Gynecol Oncol; 2009 Dec; 115(3):476-81. PubMed ID: 19818481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.